NCT02296931View on ClinicalTrials.gov

Assessment of a Syringe Pump to Pre-eclamptic Women in a Low-resource Hospital

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 3, 2017

Conditions
Pre-eclampsia
Interventions
OTHER

Saline

Standard IV Saline Fluids

DRUG

Magnesium Sulfate

The standard drug used to prevent and treat convulsions for women with pre-eclampsia and eclampsia is magnesium sulfate (MgSO4)

Trial Locations (1)

Unknown

Queen Elizabeth Central Hospital, Blantyre

All Listed Sponsors
collaborator

University of Malawi

OTHER

lead

William Marsh Rice University

OTHER

NCT02296931 - Assessment of a Syringe Pump to Pre-eclamptic Women in a Low-resource Hospital | Biotech Hunter | Biotech Hunter